| Dr Stephen Barry Sherer, MDFACC | |
|
714 Bergen Blvd, Ridgefield, NJ 07657-1425 | |
| (201) 945-3022 | |
| (201) 945-5604 |
| Full Name | Dr Stephen Barry Sherer |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 49 Years |
| Location | 714 Bergen Blvd, Ridgefield, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730156829 | NPI | - | NPPES |
| 0092076000 | Other | NJ | AMERIHEALTH |
| 0037742 | Other | NJ | GROUP HEALTH INC |
| 1053604 | Medicaid | NJ | |
| SS038A2710 | Other | NJ | EMPIRE BC/BS |
| BS470 | Other | NJ | OXFORD |
| 0092076002 | Other | NJ | AMERIHEALTH |
| 41349 | Other | NJ | AETNA |
| 0400512 | Other | NJ | UNITED HEALTHCARE |
| 436208 | Other | NJ | CIGNA |
| OK2402 | Other | NJ | HEALTHNET |
| 412574 | Other | NJ | CIGNA |
| 514069 | Other | NJ | AETNA |
| 060065908 | Other | NJ | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 37042 (New Jersey) | Primary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 37042 (New Jersey) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelcare Medical Associates Pa | 4284647868 | 182 |
| Holy Name Hospital Ekg Interpretation Group | 5294798849 | 13 |
News Archive
People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
The dermatological impact of COVID-19 is a burning topic at EADV's 2021 Spring Symposium. New research presented today highlights the effect that stringent hand hygiene during the pandemic has had on hand skin health.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that the U.S. National Cancer Institute (NCI) presented long-term (median 10-year follow-up) outcomes at the 2012 American Society of Clinical Oncology Annual Meeting (ASCO 2012) from a Phase II BiovaxID lymphoma vaccine clinical trial.
Nu Skin Enterprises, Inc. today announced record third-quarter results, with revenue of $383.6 million, a 15 percent improvement over the prior-year period. Quarterly revenue was positively impacted 4 percent by foreign currency fluctuations. Earnings per share for the quarter were $0.55, a 38 percent improvement over the prior year.
› Verified 4 days ago
| Entity Name | Holy Name Hospital Ekg Interpretation Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699805978 PECOS PAC ID: 5294798849 Enrollment ID: O20041105000062 |
News Archive
People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
The dermatological impact of COVID-19 is a burning topic at EADV's 2021 Spring Symposium. New research presented today highlights the effect that stringent hand hygiene during the pandemic has had on hand skin health.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that the U.S. National Cancer Institute (NCI) presented long-term (median 10-year follow-up) outcomes at the 2012 American Society of Clinical Oncology Annual Meeting (ASCO 2012) from a Phase II BiovaxID lymphoma vaccine clinical trial.
Nu Skin Enterprises, Inc. today announced record third-quarter results, with revenue of $383.6 million, a 15 percent improvement over the prior-year period. Quarterly revenue was positively impacted 4 percent by foreign currency fluctuations. Earnings per share for the quarter were $0.55, a 38 percent improvement over the prior year.
› Verified 4 days ago
| Entity Name | Excelcare Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992736300 PECOS PAC ID: 4284647868 Enrollment ID: O20060727000044 |
News Archive
People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
The dermatological impact of COVID-19 is a burning topic at EADV's 2021 Spring Symposium. New research presented today highlights the effect that stringent hand hygiene during the pandemic has had on hand skin health.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that the U.S. National Cancer Institute (NCI) presented long-term (median 10-year follow-up) outcomes at the 2012 American Society of Clinical Oncology Annual Meeting (ASCO 2012) from a Phase II BiovaxID lymphoma vaccine clinical trial.
Nu Skin Enterprises, Inc. today announced record third-quarter results, with revenue of $383.6 million, a 15 percent improvement over the prior-year period. Quarterly revenue was positively impacted 4 percent by foreign currency fluctuations. Earnings per share for the quarter were $0.55, a 38 percent improvement over the prior year.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Barry Sherer, MDFACC 714 Bergen Blvd, Ridgefield, NJ 07657-1425 Ph: (201) 945-3022 | Dr Stephen Barry Sherer, MDFACC 714 Bergen Blvd, Ridgefield, NJ 07657-1425 Ph: (201) 945-3022 |
News Archive
People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
The dermatological impact of COVID-19 is a burning topic at EADV's 2021 Spring Symposium. New research presented today highlights the effect that stringent hand hygiene during the pandemic has had on hand skin health.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that the U.S. National Cancer Institute (NCI) presented long-term (median 10-year follow-up) outcomes at the 2012 American Society of Clinical Oncology Annual Meeting (ASCO 2012) from a Phase II BiovaxID lymphoma vaccine clinical trial.
Nu Skin Enterprises, Inc. today announced record third-quarter results, with revenue of $383.6 million, a 15 percent improvement over the prior-year period. Quarterly revenue was positively impacted 4 percent by foreign currency fluctuations. Earnings per share for the quarter were $0.55, a 38 percent improvement over the prior year.
› Verified 4 days ago
Ms. Hrisula Sterjova, AGPCNP-BC Internal Medicine Medicare: Medicare Enrolled Practice Location: 561 Shaler Blvd Apt A, Ridgefield, NJ 07657 Phone: 201-310-1253 | |
Dr. Wonil Park, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 784 Grand Ave Ste 201, Ridgefield, NJ 07657 Phone: 201-346-0999 Fax: 201-346-0118 | |
Agop Artinian, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 477 Bergen Blvd, Ridgefield, NJ 07657 Phone: 201-967-8425 Fax: 201-967-8443 |